Steven Cohen’s Evolent Health EVH Stock Holding History

Steven Cohen’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-100,000	Closed	-$3.1M	–	1150
2021 Q3	$3.1M	Buy	+100,000	New	+$2.4M	0.01%	739

Other funds holding EVH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCM

Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return

Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Steven Cohen's EVH Position: Q1 2026 in Review

Steven Cohen sold out of Evolent Health (EVH) in Q1 2026, closing a stake of 564,954 shares — an estimated $2.26M sold.

Steven Cohen first reported a position in EVH in Q2 2017 and held it in 28 quarters. The position peaked at $91.8M in Q4 2022. 192 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

Steven Cohen reported no remaining Evolent Health position as of Q1 2026 after selling out during the quarter.
Steven Cohen sold 564,954 Evolent Health shares in Q1 2026, an estimated $2.26M.
Steven Cohen first reported a position in Evolent Health in Q2 2017 and held it in 28 quarters.
Steven Cohen's Evolent Health position peaked at $91.8M in Q4 2022.
192 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.